|
Comparison of our gene list with gene lists described in literature |
|||
| Reference: Cell lines |
A2780 vs. CP70 + C30 + C200 |
CP70 vs. C30 + C200 |
|
|
|
|||
| Up-regulated |
Down-regulated |
Down-regulated* |
|
|
|
|||
| [13]: 6 cisplatin resistant cell pairs, including A2780 and CP70 |
JUN (↑) and IFITM1 (↓) |
MRC2(↓) |
|
| [14]: A2780 and oxaliplatin resistant C10B |
FER1L3 (↑), LIPA (↑), IFITM1 (↑), NMI (↑) and ALCAM (↑) |
SOC2 (↓), MID1(↓), TFPI (↓), MMRN (↓), CCR1 (↓) and NID2 (↑) |
MMP3 (↑), SPARC (↑), FER1L3 (↑), TM4SF1 (↓), CRIM1 (↓) and PEG10 (↓) |
| [16]: 4 oxaliplatin resistant cell pairs, including A2780 and R4 |
NFE2L1 (↑), IFITM1 (↓) |
TIP120B (↑) |
TIMP2 (↑), COTL1 (↑), IL1R1 (↑), SPARC (↑) and SLC4A2 (↓) |
| [15]: A2780, cisplatin resistant ACR6 and ACRP |
S100A11 (↓) and SLC25A6 (↓) |
PEG10 (↑), TMSB4X (↓) and COL5A2 (↓) |
|
|
The arrows behind the genes indicate whether the gene was up-regulated (↑) or down-regulated (↓) in the cisplatin/oxaliplatin resistant subline(s) compared to the cisplatin/oxaliplatin sensitive parental cell line according to microarray or SAGE data of other groups. * The genes selected from factor 2 that were also described in literature were all down-regulated in C30 + C200 compared to CP70. | |||
Crijns et al. BMC Genomics 2006 7:232 doi:10.1186/1471-2164-7-232 |
|||